Larson Financial Group’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-20
Closed -$1.53K – 3818
2025
Q4
$1.53K Hold
20
– – ﹤0.01% 2836
2025
Q3
$2.32K Sell
20
-43
-68% -$5.39K ﹤0.01% 2650
2025
Q2
$9.34K Buy
+63
New +$12.6K ﹤0.01% 1836

Other funds holding MDCX

Larson Financial Group's MDCX Position: Q1 2026 in Review

Larson Financial Group sold out of Medicus Pharma (MDCX) in Q1 2026, closing a stake of 20 shares — an estimated $1.53K sold.

Larson Financial Group first reported a position in MDCX in Q2 2025 and held it in 3 quarters. The position peaked at $9.34K in Q2 2025. 22 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • Larson Financial Group reported no remaining Medicus Pharma position as of Q1 2026 after selling out during the quarter.
  • Larson Financial Group sold 20 Medicus Pharma shares in Q1 2026, an estimated $1.53K.
  • Larson Financial Group first reported a position in Medicus Pharma in Q2 2025 and held it in 3 quarters.
  • Larson Financial Group's Medicus Pharma position peaked at $9.34K in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.